{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:26Z","timestamp":1786981226599,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10792-021-01788-z","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T05:02:21Z","timestamp":1616302941000},"page":"2347-2358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases"],"prefix":"10.1007","volume":"41","author":[{"given":"Alfonso L.","family":"Sabater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Mauricio","family":"Sanchez Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Anitua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Merayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"key":"1788_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/mi.2010.26","volume":"3","author":"ME Stern","year":"2010","unstructured":"Stern ME, Schaumburg CS, Dana R et al (2010) Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol 3:425\u2013442. https:\/\/doi.org\/10.1038\/mi.2010.26","journal-title":"Mucosal Immunol"},{"key":"1788_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","volume":"379","author":"DT Tan","year":"2012","unstructured":"Tan DT, Dart JK, Holland EJ, Kinoshita S (2012) Corneal transplantation. The Lancet 379:1749\u20131761. https:\/\/doi.org\/10.1016\/S0140-6736(12)60437-1","journal-title":"The Lancet"},{"key":"1788_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1542-0124(12)70059-9","volume":"2","author":"SCG Tseng","year":"2004","unstructured":"Tseng SCG, Espana EM, Kawakita T et al (2004) How does amniotic membrane work? Ocul Surf 2:177\u2013187. https:\/\/doi.org\/10.1016\/S1542-0124(12)70059-9","journal-title":"Ocul Surf"},{"key":"1788_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exer.2015.02.016","volume":"135","author":"E Anitua","year":"2015","unstructured":"Anitua E, de la Fuente M, Muruzabal F et al (2015) Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp Eye Res 135:118\u2013126. https:\/\/doi.org\/10.1016\/j.exer.2015.02.016","journal-title":"Exp Eye Res"},{"key":"1788_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5500\/wjt.v4.i2.111","volume":"4","author":"C Malhotra","year":"2014","unstructured":"Malhotra C, Jain AK (2014) Human amniotic membrane transplantation: different modalities of its use in ophthalmology. WJT 4:111. https:\/\/doi.org\/10.5500\/wjt.v4.i2.111","journal-title":"WJT"},{"key":"1788_CR6","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/eye.2008.410","volume":"23","author":"I Rahman","year":"2009","unstructured":"Rahman I, Said DG, Maharajan VS, Dua HS (2009) Amniotic membrane in ophthalmology: indications and limitations. Eye 23:1954\u20131961. https:\/\/doi.org\/10.1038\/eye.2008.410","journal-title":"Eye"},{"key":"1788_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/archopht.116.4.431","volume":"116","author":"SCG Tseng","year":"1998","unstructured":"Tseng SCG (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431. https:\/\/doi.org\/10.1001\/archopht.116.4.431","journal-title":"Arch Ophthalmol"},{"key":"1788_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","volume":"88","author":"G Geerling","year":"2004","unstructured":"Geerling G (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467\u20131474. https:\/\/doi.org\/10.1136\/bjo.2004.044347","journal-title":"Br J Ophthalmol"},{"key":"1788_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3109\/02713683.2015.1104362","volume":"41","author":"E Anitua","year":"2016","unstructured":"Anitua E, Muruzabal F, de la Fuente M et al (2016) Plasma rich in growth factors for the treatment of ocular surface diseases. Curr Eye Res 41:875\u2013882. https:\/\/doi.org\/10.3109\/02713683.2015.1104362","journal-title":"Curr Eye Res"},{"key":"1788_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.exer.2013.07.007","volume":"115","author":"E Anitua","year":"2013","unstructured":"Anitua E, Muruzabal F, Alcalde I et al (2013) Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res 115:153\u2013161. https:\/\/doi.org\/10.1016\/j.exer.2013.07.007","journal-title":"Exp Eye Res"},{"key":"1788_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/ICO.0b013e31820d86d6","volume":"30","author":"S L\u00f3pez-Plandolit","year":"2011","unstructured":"L\u00f3pez-Plandolit S, Morales M-C, Freire V et al (2011) Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea 30:1312\u20131317. https:\/\/doi.org\/10.1097\/ICO.0b013e31820d86d6","journal-title":"Cornea"},{"key":"1788_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/ICO.0b013e3181a81820","volume":"29","author":"S L\u00f3pez-Plandolit","year":"2010","unstructured":"L\u00f3pez-Plandolit S, Morales M-C, Freire V et al (2010) Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 29:843\u2013848. https:\/\/doi.org\/10.1097\/ICO.0b013e3181a81820","journal-title":"Cornea"},{"key":"1788_CR13","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.biomaterials.2007.06.037","volume":"28","author":"E Anitua","year":"2007","unstructured":"Anitua E, S\u00e1nchez M, Orive G, And\u00eda I (2007) The potential impact of the preparation rich in growth factors (PRGF) in different medical fields\u2606. Biomaterials 28:4551\u20134560. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.06.037","journal-title":"Biomaterials"},{"key":"1788_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2230.2011.04303.x","volume":"37","author":"E Anitua","year":"2012","unstructured":"Anitua E, Alonso R, Girbau C et al (2012) Antibacterial effect of plasma rich in growth factors (PRGF\u00ae-Endoret\u00ae) against Staphylococcus aureus and Staphylococcus epidermidis strains: bacteriostatic effect of plasma rich in growth factors against Staphylococcus strains. Clin Exp Dermatol 37:652\u2013657. https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04303.x","journal-title":"Clin Exp Dermatol"},{"key":"1788_CR15","doi-asserted-by":"publisher","first-page":"e0242","DOI":"10.1097\/MD.0000000000010242","volume":"97","author":"RM Sanchez-Avila","year":"2018","unstructured":"Sanchez-Avila RM, Merayo-Lloves J, Riestra AC et al (2018) Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders. Medicine 97:e0242. https:\/\/doi.org\/10.1097\/MD.0000000000010242","journal-title":"Medicine"},{"key":"1788_CR16","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1167\/iovs.11-7302","volume":"52","author":"E Anitua","year":"2011","unstructured":"Anitua E, Sanchez M, Merayo-Lloves J et al (2011) Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-\u03b21\u2013induced myodifferentiation. Invest Ophthalmol Vis Sci 52:6066. https:\/\/doi.org\/10.1167\/iovs.11-7302","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1788_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bjo.2003.026211","volume":"88","author":"BA Noble","year":"2004","unstructured":"Noble BA (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88:647\u2013652. https:\/\/doi.org\/10.1136\/bjo.2003.026211","journal-title":"Br J Ophthalmol"},{"key":"1788_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2018.02.009","volume":"189","author":"TK Ali","year":"2018","unstructured":"Ali TK, Gibbons A, Cartes C et al (2018) Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases. Am J Ophthalmol 189:65\u201370. https:\/\/doi.org\/10.1016\/j.ajo.2018.02.009","journal-title":"Am J Ophthalmol"},{"key":"1788_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.exer.2016.08.012","volume":"151","author":"E Anitua","year":"2016","unstructured":"Anitua E, Muruzabal F, de la Fuente M et al (2016) PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model. Exp Eye Res 151:115\u2013121. https:\/\/doi.org\/10.1016\/j.exer.2016.08.012","journal-title":"Exp Eye Res"},{"key":"1788_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1600-0501.2006.01179.x","volume":"17","author":"JE Fern\u00e1ndez-Barbero","year":"2006","unstructured":"Fern\u00e1ndez-Barbero JE, Galindo-Moreno P, \u00c1vila-Ortiz G et al (2006) Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin Oral Implants Res 17:687\u2013693. https:\/\/doi.org\/10.1111\/j.1600-0501.2006.01179.x","journal-title":"Clin Oral Implants Res"},{"key":"1788_CR21","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1167\/iovs.11-7340","volume":"53","author":"V Freire","year":"2012","unstructured":"Freire V, Andollo N, Etxebarria J et al (2012) In vitro effects of three blood derivatives on human corneal epithelial cells. Invest Ophthalmol Vis Sci 53:5571. https:\/\/doi.org\/10.1167\/iovs.11-7340","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1788_CR22","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1111\/aos.12710","volume":"93","author":"E Anitua","year":"2015","unstructured":"Anitua E, Muruzabal F, Tayebba A et al (2015) Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol 93:e605\u2013e614. https:\/\/doi.org\/10.1111\/aos.12710","journal-title":"Acta Ophthalmol"},{"key":"1788_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jor.20278","volume":"25","author":"LV Schnabel","year":"2007","unstructured":"Schnabel LV, Mohammed HO, Miller BJ et al (2007) Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25:230\u2013240. https:\/\/doi.org\/10.1002\/jor.20278","journal-title":"J Orthop Res"},{"key":"1788_CR24","first-page":"2490","volume":"42","author":"O Maltseva","year":"2001","unstructured":"Maltseva O, Folger P, Zekaria D et al (2001) Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci 42:2490\u20132495","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1788_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamaophthalmol.2013.2474","volume":"131","author":"JL Alio","year":"2013","unstructured":"Alio JL, Rodriguez AE, Martinez LM, Rio AL (2013) Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. JAMA Ophthalmol 131:745. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.2474","journal-title":"JAMA Ophthalmol"},{"key":"1788_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","volume":"39","author":"JL Alio","year":"2007","unstructured":"Alio JL, Colecha JR, Pastor S et al (2007) Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res 39:124\u2013129. https:\/\/doi.org\/10.1159\/000100933","journal-title":"Ophthalmic Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01788-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T09:04:20Z","timestamp":1624871060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01788-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01788-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eduardo Anitua is the Scientific Director of BTI Biotechnology Institute. Gorka Orive is a scientist at BTI Biotechnology Institute, a dental company that investigates PRGF-Endoret technology and oral implantology. The rest of the authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent for participation was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}